Methynerve Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and associated neurological conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, modulates calcium channels to reduce neuronal excitability, thereby alleviating neuropathic pain and improving sleep quality. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, contributing to analgesic effects and mood stabilization in chronic pain states. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and neuronal metabolism. The combination in Methynerve Tablet SR offers a multimodal approach targeting pain relief, nerve healing, and psychological well-being, making it suitable for conditions such as diabetic neuropathy, postherpetic neuralgia, and peripheral neuropathies. The sustained-release mechanism ensures prolonged therapeutic plasma concentrations, improving patient compliance and minimizing dosing frequency. Methynerve Tablet SR should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, dry mouth, sedation, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiac conditions, or those taking concomitant CNS depressants.